Vincerx Pharma Inc.

NASDAQ: VINC · Real-Time Price · USD
0.05
-0.00 (-1.96%)
At close: Jun 09, 2025, 12:40 PM

Vincerx Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 915K 939K 340K
Gross Profit
n/a -915K -939K -340K
Operating Income
-31.46M -42.61M -73.57M -62.66M
Interest Income
472K 1.25M 664K n/a
Pretax Income
-30.07M -40.16M -65.37M -39.31M
Net Income
-30.07M -40.16M -57.16M -15.61M
Selling & General & Admin
15.98M 13.64M 18.95M 22.57M
Research & Development
15.49M 28.06M 52.15M 40.08M
Other Expenses
n/a n/a 1.24M -8K
Operating Expenses
31.46M 41.69M 71.11M 62.66M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 42.61M 71.11M 62.66M
Income Tax Expense
n/a n/a -8.21M -23.7M
Shares Outstanding (Basic)
1.9M 21.3M 21.03M 17.18M
Shares Outstanding (Diluted)
1.9M 21.3M 21.03M 17.18M
EPS (Basic)
-15.85 -1.89 -2.72 -0.91
EPS (Diluted)
-15.85 -1.89 -2.72 -0.91
EBITDA
-31.46M -42.56M -68.67M -62.66M
EBIT
n/a -40.16M -68.72M -62.66M
Depreciation & Amortization
n/a 915K 939K 340K